Clinical Trial Update: Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia. [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial update evaluating safety and efficacy of ZS (Sodium Zirconium Cyclosilicate) 10g once daily to extend the ZS-004 study in hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• ZS

Snippet

Sponsor: ZS Pharma, Inc. | Conditions: Hyperkalemia | Phase 3 | Status: COMPLETED | Results posted: 2018-08-15